Author: Michael

Later-stage financings dominate as global longev

Later-stage financings dominate as global longev

Later-stage financings dominate as global longev

Peter Hamley, Chief Scientific Officer of Samsar

Peter Hamley, Chief Scientific Officer of Samsar

Peter Hamley, Chief Scientific Officer of Samsar

Silicon Valley longevity biotech Read More

Silicon Valley longevity biotech Read More

Silicon Valley longevity biotech Read More

A lump sum of at least £1,655 has failed to reach